FSD Pharma, Inc.
- Country
- 🇨🇦Canada
- Ownership
- Public
- Established
- 1994-10-20
- Employees
- 11
- Market Cap
- -
- Website
- http://www.fsdpharma.com
Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers
- First Posted Date
- 2023-04-20
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- FSD Pharma, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05821387
- Locations
- 🇨🇦
Biopharma Services Incorporated, Toronto, Ontario, Canada
Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)
- Conditions
- Mast Cell Activation Disorder IdiopathicMast Cell Activation Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-12-15
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- FSD Pharma, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT05652907
- Locations
- 🇺🇸
Saint Charles Clinical Research, Weldon Spring, Missouri, United States
🇺🇸Norman Marcus Pain Institute, New York, New York, United States
🇨🇦Toronto Rehabilitation Institute, Toronto, Ontario, Canada
Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2020-11-06
- Last Posted Date
- 2022-12-05
- Lead Sponsor
- FSD Pharma, Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT04619706
- Locations
- 🇺🇸
Miami, Florida, Miami, Florida, United States
🇺🇸Palms of Pasadena Hospital, Saint Petersburg, Florida, Saint Petersburg, Florida, United States
🇺🇸Theia Clinical Research, St. Petersburg, Florida, Saint Petersburg, Florida, United States